Arin战术极端风险主动型ETF ATTR 深 沪
已收盘 05-15 16:00:00 美东时间
94.0657
-0.184
-0.19%
华盛通- 最 高94.0657
- 今 开94.2493
- 成交量 4股
- 最 低 94.0657
- 昨 收 94.2493
- 总市值 9304.04万
- 52周最高 94.2493
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 88.71
- 委 比 0.00%
- 总股本 98.91万
- 历史最高 94.2493
- 量 比 0
- 振 幅 0.00%
- 历史最低 88.71
- 每 手 1
- 风险率 1.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Ebay Rejects Unsolicited Proposal From Gamestop
BRIEF-Ebay Rejects Unsolicited Proposal From Gamestop eBay Inc EBAY.O : EBAY REJECTS UNSOLICITED PROPOSAL FROM GAMESTOP EBAY: CONCLUDED THAT GAMESTOP PROPOSAL IS NEITHER "CREDIBLE NOR ATTRACTIVE" EBAY: BOARD IS CONFIDENT THAT CO, UNDER ITS CURRENT MANAGEMENT TEAM, IS WELL-POSITIONED TO CONTINUE TO
05-12 18:01
Alnylam says HELIOS-B analysis shows vutrisiran benefit across ATTR-CM patient groups
Alnylam says HELIOS-B analysis shows vutrisiran benefit across ATTR-CM patient groups Alnylam highlighted new analyses from HELIOS-B Phase 3 trial of vutrisiran in ATTR-CM, with results already presented at Heart Failure 2026. Analyses showed clinical benefit remained consistent across harder-to-tre
05-12 14:30
BridgeBio falls despite new Attruby data
BridgeBio Pharma (BBIO) is down ~4% in Monday trading despite releasing phase 3 heart failure data for Attruby (acoramidis). Results from the ATTRibute-CM study found that the drug led to consistent a...
05-12 03:11
BridgeBio Pharma's Acoramidis Receives Marketing Authorization From Brazil's Health Regulatory Agency To Treat Transthyretin Amyloidosis
BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, today announced the Brazilian Health Regulatory Agency (ANVISA) has granted
05-06 19:42
Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View
Pfizer beats Q1 estimates with revenue growth and strong pipeline progress, extends Vyndamax patent outlook, and backs 2026 guidance.
05-06 00:15
Intellia Therapeutics prices $180M stock offering at discount
Intellia Therapeutics (NTLA) on Wednesday said it priced an underwritten public offering of 16.74M shares at $10.75 each, for expected gross proceeds of about $180M. Shares down -11% in premarket. Th...
04-29 20:50
Pfizer Stock Is Declining Today: What's Happening?
Pfizer Inc. shares are dipping on Tuesday. The company announced settlement agreements extending the effective U.S. patent life of Vyndamax.
04-29 01:23
Prothena Announces Coramitug Amyloid Depleter Antibody Receives FDA's Fast Track Designation To Treat ATTR Amyloidosis With Cardiomyopathy
Prothena Corporation plc (NASDAQ:PRTA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to coramitug, a potential best-in-class amyloid depleter antibody currently in
04-28 04:12
BRIEF-TSMC: Demand Is Very Robust
BRIEF-TSMC: Demand Is Very Robust April 16 (Reuters) - Taiwan Semiconductor Manufacturing Co Ltd 2330.TW : TSMC: DEMAND IS VERY ROBUST TSMC: DEMAND CONTINUES TO INCREASE TSMC: CUSTOMERS GIVE POSITIVE OUTLOOK TSMC: WE HAVE TO SPEED UP BUILD UP OF CLEAN ROOMS, BUYING TOOLS TSMC: AI IS SO STRONG TSMC:
04-16 15:07
Iran war brings US close to net crude exporter for first time since World War Two
Iran war brings US close to net crude exporter for first time since World War Two Net imports of US crude narrows to lowest on record last week US exports climb to seven-month high on wide Brent-WTI spread US exports near capacity limits, analysts and traders say By Arathy Somasekhar and Georgina Mc
04-16 10:28
